Community Urology Services

Unknown

Value

£0

Classifications

  • Health services

Tags

  • tenderUpdate

Published

3 years ago

Description

Bristol, North Somerset and South Gloucestershire ICB (BNSSG ICB) is extending the Specialist Community Urology Service with GP Care UK Ltd to 31st March 2025.
The Specialist Community Urology Service will provide a rapid access, one stop assessment and diagnostic service for routine urological conditions, delivered in non-hospital settings linked to the six GP Localities.  The provider will offer the following tests as part of the service, when clinically appropriate:
•	Flexible cystoscopy
•	Ultrasound scan
•	Flow rate
•	Urine analysis
The Service continues to provide excellent services and achieves very good reporting results, with no major concerns from the ICB. They have worked with the ICB to foster strong working relationships with local Trusts, helping to develop an integrated pathway for patients. Over recent months, the provider has been completing the onboarding of Trust consultants and has reported that this transition is developing well. 
The benefit of this collaboration between providers is evident in the work that has taken place between the provider, the Trust and the ICB Referrals Team. Given the backlogs the Acute providers are facing since the COVID-19 pandemic and in order to relieve pressure on the Trust, the three parties have been working to undertake a review of referrals, which were originally sent directly to the Trust. As a result, many of these referrals are being redirected to the provider, to divert some of the workload from the Trust which in turn is releasing capacity within the acute provision.
In addition, the current service is working toward the ambition for an integrated care system and the current service is a key enabler in the delivery of the Healthier Together vision to move activity from hospitals to community / primary care settings.
Recognising the pressures within the system and the continued impact of the COVID-19 pandemic on services, the ICB has decided to direct-award a new Urology contract to GP Care under Regulation 32(2)(b)(ii) of the Public Contracts Regulations 2015, and that competition is absent for technical reasons.
The value of this notice is £3,095,284 for the period 1 October 2021 to 31 March 2025.

Similar Contracts

Open

Provision of Hypertension and Lipids Management Services

NHS Norfolk and Waveney Integrated Care Board is seeking a procure a Hypertension and Lipids Optimisation service. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.<br/><br/>NHS Norfolk and Waveney Integrated Care Board is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.<br/><br/>The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.<br/><br/>The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.<br/>Prescribers must be able to initiate relevant medicines.<br/>Prescribers must initiate medicines in line with N&W criteria.<br/><br/>Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.<br/><br/>Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.<br/><br/>The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline unknown